Today marks the launch of the CEPI 3.0 Investment Case and Strategy. CEPI 3.0 – our 2027-2031 strategy - is the next step in CEPI’s mission to transform the way the world tackles epidemic and pandemic threats. Discover more in the press release ⬇️

A Phase I study in healthy African adults assessed oxfendazole, a promising option for filarial diseases such as onchocerciasis. The findings suggest that a five day course of 400 mg daily, or 50 mg twice daily, reaches target exposure with low safety concerns. @PLOSNTDs doi.org/10.1002/psp4...

The future of African public health must be collaborative, data-driven & above all, people-centred. The recent partnership between @dndi.org & @aphrc.bsky.social will be a gamechanger in strengthening the health ecosystem at large. #HealthEquity Read more🔗 bit.ly/4tynePW

We’re at the 16th KEMRI Annual Scientific & Health (KASH) Conference 2026! Visit the DNDi booth to meet our team and learn about our work delivering safe, effective, and affordable treatments for neglected diseases. #KASH2026

Great to see the German NTDs Network bringing parliamentarians together to relaunch the parliamentary working group on neglected tropical diseases👏 Thank you to the MPs who have committed to supporting global health and giving visibility to people affected by #NTDs.

Last week, @dndi.org announced a new memorandum of understanding with the African Population and Health Research Center aimed at helping translate African-led research into transformative innovations and health policies. www.ghtcoalition.org/blog/researc...

Governments play a critical role in ensuring that public investments in health innovation deliver public value. At #EB158, we urged WHO Member States to establish policies on conditions for publicly funded research. Our intervention at @who.int 👉 bit.ly/4auqBj2

InfoChagas is an important source of support for people at risk of Chagas disease. This study shows that people in high burden countries use it for guidance on treatment access, transmission risks & referrals, helping reduce major care gaps. doi.org/10.1371/jour... @plos.org

Chronic Chagas heart disease is still difficult to manage. This study outlines what effective care should include at primary, secondary & tertiary levels with real world models showing how simple, scalable steps can improve diagnosis & treatment @worldheart.org globalheartjournal.com/articles/10....

The world remains far off track on health-related SDGs, and R&D gaps continue to undermine progress. At #EB158, we urged WHO Member States to ensure sustained investment in new and effective health tools. Our intervention at @who.int 👉 bit.ly/4auqBj2

Despite some progress, the fight against many NTDs remains off track. At #EB158 we urged Member States to fund NTDs, advance R&D, support inclusive research, & tackle climate-sensitive diseases. Our intervention at @who.int 👉 bit.ly/4auqBj2

We are deeply saddened by the passing of Sir Nicholas White. Through a decade as Chair of our Scientific Advisory Committee, Nick guided & strengthened our research with wisdom, integrity & deep commitment to the people we serve. We honour his remarkable legacy and extend our heartfelt condolences.

As urban populations grow & the climate warms, a @lshtm.bsky.social RAFT webinar explores how @thelancet.com’s Arbovirus Commission’s Building Out Aedes framework aims to help eliminate mosquito habitats & protect communities from diseases like dengue, Zika & more. Join here: bit.ly/RAFTroadmapw...

“Underreporting and weak surveillance continue to cloud the true burden of NTDs,” said Sanjay Sarin, our Asia continental lead, to @nature.com India. “Cases are often missed in exactly the places where disease risk is highest.” Read more ⤵️ www.nature.com/articles/d44...

On #WorldNTDDay, @imperialcollegeldn.bsky.social + @dndi.org strengthen their partnership to speed up new treatments for #NeglectedDiseases affecting 1 billion+ people worldwide. 🌍 From #AI to drug discovery, we’re working to turn science into real-world impact. www.imperial.ac.uk/news/article...

🌍 For #WorldNTDDay, we’re spotlighting @moniquewasunna.bsky.social (MSc Clinical Tropical Medicine, 1986; PhD Medicine, 1991) — whose leadership advancing equitable access to treatments and clinical research for NTDs across East Africa shows the impact of sustained collaboration.

We look forward to attending @globalhealthedctp3.bsky.social's Info Day on Thursday 5 February! More info 👉 bit.ly/3OcDaXC

⚕️Tomorrow is #WorldNTDDay🌐2026, and Chagas Coalition will be supporting it through a webinar with our colleagues from PAHO & @dndi.org. It's about data management related to these 21 neglected diseases ✍️ paho-org.zoom.us/webinar/regi... On January 30, let's #BeatNTDs & call for #UniteActEliminate

"For millions of women and girls across sub-Saharan Africa, routine daily tasks fetching water, washing clothes, bathing in freshwater lakes and rivers expose them to a hidden and devastating disease." Read more 👉 healthbusiness.co.ke/9841/fgs-mis... @HealthBizKE

📢 Today is #WorldNTDDay! Over 1B people are affected by neglected tropical diseases. Too many still lack safe & effective treatments. 👉 Share this post to support science, innovation & global health funding. #EndTheNeglect #BeatNTDs #UniteActEliminate

🚨 Neglected tropical diseases (NTDs) affect more than 1 billion people worldwide, yet effective treatments and diagnostics are still often unavailable, unsuitable, or unsafe. #EndTheNeglect #beatNTDs #UniteActEliminate @dndi.org

Warm congratulations to Prof. Shyam Sundar on receiving the Padma Shri for his outstanding contribution to the diagnosis, treatment & control of #kalaazar. 👏 A well-deserved honour recognizing a lifetime dedicated to improving care & outcomes for affected communities. #beatNTDs #leishmaniasis

We are not ready for the next pandemic. Latest report from the #100DaysMission finds declining investment in R&D for pandemic countermeasures, with the state of the therapeutics pipeline particularly dire. Read more 👉 ippsecretariat.org/news/pandemi... @ippsecretariat.org @drluispizarro.bsky.social

🤝We signed an MoU with @aphrc.bsky.social to drive innovation, ethical data sharing & climate-resilient health solutions. This partnership is a commitment to transforming African-led research into impactful health policy & life-saving medical tools. More 👉 bit.ly/3O5GYtE @eadirectordndi.bsky.social

30 January is #WorldNTDDay: We need greater investment in research & innovation to deliver life-saving solutions to the people living with neglected tropical diseases. Join our social media campaign & help raise awareness 👉 https://bit.ly/4pHmtkk #beatNTDs #UniteActEliminate

Luis Pizarro in BMJ Global Health: Global health is in crisis: to reach neglected patients, we need to reimagine medical research gh.bmj.com/content/11/1...

🗓️ 30 enero | #WorldNTDDay 2026 Celebramos junto a OPS 📊 "Reduciendo las brechas en los datos sobre enfermedades tropicales desatendidas" (ETD), un #webinario sobre las estrategias para su recopilación, gestión y difusión. ℹ️ coalicionchagas.org/event/reduci... #BeatNTDs #NTDs #Chagas #Agenda2030

Dive into global health! Enroll in our MOOC on Neglected Tropical Diseases. Learn about NTDs, control strategies, and more. Join the fight against these ancient diseases! 🌍 👉 Enroll now: www.fun-mooc.fr/en/courses/n...

What has the biggest impact on the immune response to SARS-CoV-2 in African populations? Find out what this 4-country study discovered: doi.org/10.1186/s129... @BMCMedicine

Less than 30% of Phase I trial participants are women. This is an issue, as this can lead to unsuitable drug dosages and put women's health at risk. Insightful article by Jamwal Nidhi, featuring insights from our recent InSciLead report. @kashmirtimes.bsky.social kashmirtimes.com/opinion/comm...

Microbial infections are surging. Surrounding antimicrobial drugs with a lipid bilayer (liposome) can reduce side effects and improve efficacy, but can be challenging. We need simpler, scalable, affordable liposome production. @sciencedirect.bsky.social www.sciencedirect.com/science/arti...

What impact does the global health crisis have on non-profit medical R&D organizations bringing life-saving innovation to millions of neglected people? Our executive director @drluispizarro.bsky.social outlines key challenges and possible solutions in @GlobalHealthBMJ gh.bmj.com/content/11/1...

To learn about the global burden of cryptococcal disease, limitations of currently available treatments, attributes of much-needed novel treatments, and potential drug discovery and development pathways, click here www.journalofinfection.com/article/S016...

How does treatment for #PKDL affect the #leishmaniasis parasite and the human immune system? We need to know so that we can get the dosing right. Read more here doi.org/10.1002/cpt....

✨We wish you a joyful holiday season & happy 2026! We deeply appreciate the colleagues, supporters, partners, & friends who have joined us in our journey putting equity at the heart of medical innovation. We look forward to continuing to innovate together in the year to come!

On his motorcycle, Andrew Ochieng reaches remote communities on the Kenya–Uganda border to diagnose visceral leishmaniasis and refer people to treatment. Kang-Chun Cheng met villagers, patients and researchers, and tells their stories for BBC 👇 www.bbc.com/future/artic...

An individual participant data platform at #IDDO hosts data from nearly 15,000 patients with #leishmaniasis; this can enable new evidence generation and serve as historical data to support accelerated drug development. Read more at doi.org/10.1186/s130... @BioMedCentral

We’re pleased to introduce the 2025-2026 cohort of the #WithoutBordersMediaFellowship! This year, the fellows will spotlight #NTDs & gender-responsive R&D, along with the systemic barriers shaping health outcomes in #SouthAsia. tinyurl.com/3x74zku3 @gardp.bsky.social #beatNTDs

👏 Congratulations @gardp.bsky.social on this major achievement—a real breakthrough for patients and an important win in the fight against antimicrobial resistance! We’re especially delighted to see this achievement given our shared history and our joint CMC platform. #Gonorrhoea #AMR

Congratulations to Nurse Luke Kanyang'areng on his nomination to the list of #Top100Kenyans2025. A well-deserved recognition for his work as a patient advocate, champion for neglected populations in Kenya & reinforcing primary healthcare delivery. Read more ➡️ www.kenyans.co.ke/personality/...

Dengue outbreaks in Cuba (where 33 people died in recent months) and Bangladesh (394 deaths this year). The disease is fueled by climate change and globalization. Cases are almost doubling each year since 2021. There is still no specific treatment. www.bssnews.net/news/338636

We are pleased to welcome 5 new members to DNDi’s Board of Directors. Their leadership, expertise, and long-standing commitment to global health will help strengthen our unique collaborations with our founding partners & further embed patient engagement at the heart of our work.

📖 We spoke with Dr Markus Fraundorfer about his new independent study on the impact of our collaborative, not-for-profit drug development model. In this video, he shares his motivation for the book, key insights, and why the topic matters for global health today. www.youtube.com/shorts/x3CG_...

Results from a Phase II clinical trial of a promising dengue antiviral developed by Johnson & Johnson have been published by @nejm.org. The findings are promising, but further development is needed. There is still no specific treatment for #dengue. www.science.org/content/arti...

'It feels as if the disease is eating me from the inside.' In Turkana, Kenya, @efe.com shares harrowing stories of people with mycetoma, a neglected disease that empoverishes communities. 'I dont know how I'll pay school fees for my five children'. www.swissinfo.ch/spa/%22como-...

#Leishmaniasis is an endemic disease caused by Leishmania parasites and transmitted through the bite of female sand flies https://www.nature.c...

Important news for #dengue today! We congratulate the Instituto Butantan in Brazil for the approval today of its single-dose dengue vaccine by the Brazilian regulatory authority ANVISA. Our take by @andre-siqueira.bsky.social #Treatment4Dengue #dengue

Independent journalist Mansi Vijay, a 2024 MSF South Asia–DNDi Media Fellow, has been honoured with the Laadli Media Award for Gender Sensitivity for her story on how women confront #LymphaticFilariasis & the stigma, silence & barriers around it. 📰 tinyurl.com/4856udhc #Journalism @msf.ca

‘Any organization that works in R&D has a duty to have proper governance that includes peer review.’ 📽️ Watch our conversation with Dr Pauline Williams, our new Scientific Advisory Committee chair: youtube.com/watch?v=m4TC... 👏 Welcome to the role!

Carolina Batista, our Latin America Board President, grew up with Amazonian roots, worked closely with Indigenous communities, and now leads in global health. Here’s her message to #COP30⤵️ youtube.com/shorts/cNoWL...